Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

65.67
-2.8900-4.22%
Pre-market: 66.000.3300+0.50%04:17 EDT
Volume:905.72K
Turnover:59.52M
Market Cap:5.44B
PE:8.44
High:68.12
Open:67.91
Low:64.85
Close:68.56
52wk High:87.50
52wk Low:35.95
Shares:82.77M
Float Shares:72.98M
Volume Ratio:0.64
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.78
EPS(LYR):7.78
ROE:-7740.12%
ROA:23.26%
PB:-26.48
PE(LYR):8.44

Loading ...

PTC Therapeutics sees 2026 product revenue up 19%-36%to $700M-$800M

TIPRANKS
·
Feb 20

PTC Therapeutics Q4 EPS $(1.67) Misses $0.07 Estimate, Sales $164.677M Miss $276.665M Estimate

Benzinga
·
Feb 20

PTC Therapeutics posts FY 2025 total revenues of USD 1.73B**2.15x**

Reuters
·
Feb 20

BRIEF-PTC Therapeutics Q4 Net Income USD -134.965 Million

Reuters
·
Feb 20

PTC Therapeutics Faces Translarna Setback While Valuation Signals Potential Upside

Simply Wall St.
·
Feb 18

TD Cowen Remains a Hold on PTC Therapeutics (PTCT)

TIPRANKS
·
Feb 13

BUZZ-PTC Therapeutics falls after withdrawing muscle disorder drug marketing application

Reuters
·
Feb 13

PTC Therapeutics Withdraws Translarna NDA After FDA Feedback

TIPRANKS
·
Feb 13

PTC Therapeutics Inc - Withdraws Nda Resubmission for Translarna

THOMSON REUTERS
·
Feb 13

PTC Therapeutics Provides Regulatory Update on Translarna™

THOMSON REUTERS
·
Feb 13

PTC Therapeutics Inc - Withdrawal Following FDA Feedback on Application Review

THOMSON REUTERS
·
Feb 13

Earning Preview: PTC Therapeutics Q4 revenue is expected to increase by 19.03%, and institutional views are to be added

Earnings Agent
·
Feb 12

PTC Therapeutics Inc. to Report Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Feb 05

PTC Therapeutics price target raised to $97 from $96 at BofA

TIPRANKS
·
Jan 30

Citi Keeps Their Hold Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Jan 30

PTC Therapeutics price target raised to $75 from $63 at TD Cowen

TIPRANKS
·
Jan 29

PTC Therapeutics Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Jan 28

PTC Therapeutics assumed with Overweight from Equal Weight at Barclays

TIPRANKS
·
Jan 28

Does 2026 Revenue Guidance And Sephience Momentum Change The Bull Case For PTC Therapeutics (PTCT)?

Simply Wall St.
·
Jan 15

Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (PTCT), Revolution Medicines (RVMD) and West Pharmaceutical Services (WST)

TIPRANKS
·
Jan 13